The dysregulated expression of Smurf2 has been reported across a wide spectrum of human tumours, such as colorectal carcinoma, pancreatic cancer, lung cancer and hepatocellular carcinomas [18, 19, 20]. Here, SMURF2 is linked to neoplasm.